Moolec ScienceMLEC -1.04%46 PB Ratio is 0.60 as of Jun. 26, 2026, which is 96% below its 10-year median of 13.66. GuruFocus rates MLEC with a GF Score™ of 46/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 1,232 Biotechnology companies, Moolec Science ranks better than 92.13% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Moolec Science's share price is $7.60. Moolec Science's Book Value per Share for the quarter that ended in Dec. 2025 was $12.69. Hence, Moolec Science's PB Ratio of today is 0.60.
Good Sign:
Moolec Science SA stock PB Ratio (=0.61) is close to 3-year low of 0.61.
The historical rank and industry rank for Moolec Science's PB Ratio or its related term are showing as below:
MLEC'
s PB Ratio Range Over the Past 10 Years
Min: 0.6 Med: 13.66 Max: 33.74
Current: 0.6
During the past 5 years, Moolec Science's highest PB Ratio was 33.74. The lowest was 0.60. And the median was 13.66.
MLEC's PB Ratio is ranked better than 92.13% of 1232
companies
in the Biotechnology industry
Industry Median: 2.8
vs MLEC: 0.60
During the past 12 months, Moolec Science's average Book Value Per Share Growth Rate was 21.20% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Moolec Science was -39.20% per year. The lowest was -39.20% per year. And the median was -39.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Moolec Science PB Ratio Related Terms
Moolec Science PB Ratio Historical Data
* Premium members only.
The historical data trend for Moolec Science's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Moolec Science's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moolec Science PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moolec Science's PB Ratio distribution charts can be found below:
* The bar in red indicates where Moolec Science's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Moolec Science's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Moolec Science (MLEC) has a PB Ratio of 0.60 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Moolec Science and its competitors. This is 96% below median its historical median of 13.66. Over the past decade, Moolec Science's PB Ratio has ranged from 0.60 to 33.74. According to the industry distribution chart, Moolec Science ranks #97 out of 1232 companies in the Biotechnology industry, placing it in the top 7.9%.
Is Moolec Science's PB Ratio too high?
Moolec Science's current PB Ratio of 0.60 is 96% below median its 10-year median of 13.66. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 33.74. The Biotechnology industry median PB Ratio is 2.80. Moolec Science's value of 0.60 is 78.6% below this industry median. Based on the distribution chart, Moolec Science ranks #97 out of 1232 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Moolec Science has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's PB Ratio compare to RVPH and CDIO?
According to the Biotechnology industry distribution chart, Moolec Science ranks #97 out of 1232 companies for PB Ratio. This places Moolec Science in the top 8% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.80. Moolec Science's value of 0.60 is 78.6% below this benchmark. Historically, Moolec Science's own PB Ratio has ranged from 0.60 to 33.74 over the past decade. While the company's 10-year median is 13.66 vs. the industry median of 2.80, Moolec Science has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.80, based on 1,232 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moolec Science's current PB Ratio of 0.60 is 78.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Moolec Science and its competitors. For the Biotechnology industry, the median PB Ratio is 2.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moolec Science's current PB Ratio is 0.60, which is 96% below median its own 10-year median of 13.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.60 — trading 91% below its estimated fair value. The current PB Ratio is 0.60, which is 96% below median its 10-year median of 13.66 and 78.6% below the Biotechnology industry median of 2.80. Moolec Science's overall GF Score™ is 46/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Moolec Science (MLEC), the current PB Ratio is 0.60 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moolec Science (MLEC) Overvalued in 2026?
Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued.
The current stock price of $7.60 is trading 91% below its estimated GF Value™ of $84.84.
GuruFocus considers Moolec Science to be Possible Value Trap.
Key valuation signals for MLEC:
PB Ratio: 0.60 (96% below median its 10-year median of 13.66)
GF Value™: $84.84 vs. price of $7.60 (91% below fair value)
Industry Position: 78.6% below the Biotechnology median (#97 of 1232)
No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
46GF Score
Get the complete analysis for MLEC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLEC has been successfully added to your 
